9BIC
N-Me-D-Leu2,D-Thr5-clovibactin
9BIC の概要
| エントリーDOI | 10.2210/pdb9bic/pdb |
| 分子名称 | PHE-MLU-DLY-SER-DTH-ALA-LEU-LEU, CADMIUM ION, SULFATE ION, ... (4 entities in total) |
| 機能のキーワード | depsipeptide, antibiotic |
| 由来する生物種 | Eleftheria |
| タンパク質・核酸の鎖数 | 8 |
| 化学式量合計 | 7986.80 |
| 構造登録者 | |
| 主引用文献 | Brunicardi, J.E.H.,Griffin, J.H.,Ferracane, M.J.,Kreutzer, A.G.,Small, J.,Mendoza, A.T.,Ziller, J.W.,Nowick, J.S. Structure-Activity Relationship Studies of the Peptide Antibiotic Clovibactin. J.Org.Chem., 89:12479-12484, 2024 Cited by PubMed Abstract: Our laboratory reported the chemical synthesis and stereochemical assignment of the recently discovered peptide antibiotic clovibactin. The current paper reports an improved, gram-scale synthesis of the amino acid building block Fmoc-(2,3)-3-hydroxyasparagine-OH that enables structure-activity relationship studies of clovibactin. An alanine scan reveals that residues Phe, d-Leu, Ser, Leu, and Leu are important for antibiotic activity. The side-chain amide group of the rare d-Hyn residue is not essential to activity and can be replaced with a methyl group with a moderate loss of activity. An acyclic clovibactin analogue reveals that the macrolactone ring is essential to antibiotic activity. The enantiomer of clovibactin is active, albeit somewhat less so than clovibactin. A conformationally constrained clovibactin analogue retains moderate antibiotic activity, while a backbone -methylated analogue is almost completely inactive. X-ray crystallography of these two analogues reveals that the macrolactone ring adopts a crown-like conformation that binds anions. PubMed: 39178334DOI: 10.1021/acs.joc.4c01414 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.05 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






